APOL1 and chronic kidney disease: Current therapies for chronic kidney disease are less effective at preventing progressive loss of kidney function in individuals with APOL1 high risk genotype, compared to other forms of glomerular disease, even when there may be a reduction in proteinuria in a particular patient.